Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
11,61 USD | -0,34 % | -3,73 % | +326,84 % |
Resumen de negocios
Número de empleados: 11
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Punit Dhillon
CEO | Chief Executive Officer | 44 | 19/01/18 |
Director of Finance/CFO | - | 05/10/21 | |
Chief Tech/Sci/R&D Officer | 52 | 13/12/22 | |
Karam Takhar
IRC | Investor Relations Contact | - | - |
Rhea Williams
LAW | General Counsel | - | 07/10/21 |
Thomas S. Kim
LAW | General Counsel | - | - |
Tu Diep
PRN | Corporate Officer/Principal | 43 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 77 | 07/08/20 | |
Praveen Tyle
BRD | Director/Board Member | 64 | 22/07/21 |
Andrew Schwab
BRD | Director/Board Member | 53 | 18/08/23 |
Paul Grayson
BRD | Director/Board Member | - | 18/08/23 |
Punit Dhillon
CEO | Chief Executive Officer | 44 | 19/01/18 |
Keith Ward
BRD | Director/Board Member | 54 | 14/12/21 |
Deborah Charych
BRD | Director/Board Member | - | 14/02/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 28 067 907 | 26 079 747 ( 92,92 %) | 0 | 92,92 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+326,84 % | 326 M | |
+43,36 % | 54,63 mil M | |
-5,31 % | 39,92 mil M | |
+37,52 % | 38,82 mil M | |
+14,75 % | 26,86 mil M | |
-12,56 % | 26,22 mil M | |
-22,45 % | 18,78 mil M | |
+25,12 % | 12,21 mil M | |
+0,04 % | 12,16 mil M | |
+26,04 % | 11,94 mil M |
- Bolsa de valores
- Acciones
- Acción EMBI
- Empresa Skye Bioscience, Inc.